Dianthus starts Phase 3 trial of claseprubart in myasthenia gravis

June 29, 2026 7:01 AM

Dianthus Therapeutics (Nasdaq: DNTH) announced the initiation of the EMERGE Phase 3 trial evaluating claseprubart in generalized Myasthenia Gravis (gMG) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found